Dr. Andrea Staack, MD

Dr. Staack practices at Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California.

Dr. Staack's NPI, 1578705208, was assigned on March 26, 2009. Dr. Staack graduated from Charité - Universitätsmedizin Berlin in 1999. Dr. Staack holds California license F5519.

Dr. Staack's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD, at 11370 Anderson St, Loma Linda, CA 92354.

Dr. Staack's primary practice is Loma Linda University Medical Cente - Center for Restorative Neurology - HOPD in Loma Linda, California. Dr. Staack is also affiliated with Loma Linda University Medical Center. The medical group on file is Loma Linda University Faculty Medical Group (LLUFMG). Dmand AI also links Dr. Staack to 1 more group practice or clinic and 1 hospital outpatient department, each named with a free account. Dr. Staack's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Staack practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Staack's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Staack is licensed in California.

Dmand AI lists bladder disease, kidney cysts, kidney stone disease, pelvic prolapse, urinary endoscopy, urine flow blockage, UTI and vaginal prolapse repair among the conditions Dr. Staack treats.

CMS data shows 5,275 Medicare services from Dr. Staack across 24 procedure codes in 2024, for 341 Medicare patients. Medicare paid $146,526 for them.

CMS counts 341 Medicare patients who saw Dr. Staack in 2024. The largest group is 75 to 84, with 136 patients. 75% of them have high blood pressure, and 73% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.48, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Staack's median patient age at 73, with 95% women.

In 2024, Dr. Staack wrote 1,454 Medicare Part D claims for 368 patients. 79% of them were for generic drugs. CMS names the drug for 1,323 of them, across 17 drugs with 11 or more claims each, at $321,715 in total drug cost. In 2023, CMS named 1,149 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Staack for performance year 2024, reported as part of a group. Dr. Staack accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Staack as offering telehealth.

Dmand AI links 21 papers to Dr. Staack, published from 2015 to 2024. 2015 was the busiest year, with 2. The most frequent topics are Caffeine, Cell Differentiation and Cystoscopy. Dr. Staack has published most often in Neurourol Urodyn. Dr. Staack's most frequent co-authors are Hillary J. Wagner, MD, Muhannad Mahmoud Alsyouf, MD and Peter R. Carroll, MD.

Dmand AI links Dr. Staack to 4 clinical trials. Conditions studied include Urinary Bladder, Overactive, Lower Urinary Tract Symptoms and Personal Satisfaction. Loma Linda University sponsors the most, 4.

CMS Open Payments shows 140 general payments to Dr. Staack from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 97% of the total. Medtronic, Inc. paid the most, $2,061.

Dr. Staack graduated from Charité - Universitätsmedizin Berlin in 1999. Dr. Staack is a member of American Society for Urology and SUFU.

Dr. Staack is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.